Synthesis of European pharmacopoeial impurities A , B , C , and D of cabergoline

  title={Synthesis of European pharmacopoeial impurities A , B , C , and D of cabergoline},
  author={J. Wagger and Alja{\vz} Po{\vz}es and F. Po{\vz}gan},
  journal={RSC Advances},
For the use of analytics, European pharmacopoeial impurities A, B, C, and D of cabergoline were synthesized. Ergocryptine was chosen as a starting material and synthesis was accomplished via two approaches, different in length and stereochemical outcome. A longer, indirect approach was realized through otherwise problematic oxidations of the 9,10-dihidrolysergol derivative, to the corresponding aldehyde and carboxylic acid. This was achieved by the use of activated DMSO and a Pinnick oxidation… Expand
3 Citations

Figures from this paper

Total synthesis of dihydrolysergic acid and dihydrolysergol: development of a divergent synthetic strategy applicable to rapid assembly of D-ring analogs.
By design, the use of the same ketone-derived enamine and a set of related complementary heterocyclic azadiene [4 + 2] cycloaddition reactions permitted the late stage divergent preparation of a series of alternative heterocyClic derivatives not readily accessible by more conventional approaches. Expand
Ergot alkaloids: synthetic approaches to lysergic acid and clavine alkaloids.
This review re-introduced the history of ergot alkaloids, and summarized all the natural products and semi-synthetic derivatives of er GOT alkaloid drugs from raw materials obtained by fermentation since 2000. Expand
A DMAP-Catalyzed Approach to the Industrial-Scale Preparation of N-6-Demethylated 9,10-Dihydrolysergic Acid Methyl Ester: A Key Cabergoline and Pergolide Precursor
A scalable new approach for the preparation of N-6-demethylated 9,10-dihydrolysergic acid methyl ester using 2,2,2-trichloroethyl chloroformate was developed. A key discovery that enabled theExpand


A practical synthesis of cabergoline.
An improved process was developed that eliminates this hazardous reaction in the existing process and provides a mild and efficient means of forming the unsymmetrical N-acylurea. Expand
Studies on oxidation of ergot alkaloids: oxidation and desaturation of dihydrolysergol—stereochemical requirements
Abstract A new method for the oxidation of ergoline alcohols to aldehydes was found (TFFA–DMSO, −78 °C, then DIPEA). Structural features of ergolines required for successful C7–C8 double bondExpand
Synthesis and nidation inhibitory activity of a new class of ergoline derivatives
Abstract The synthesis and the nidation inhibitory activity (indirect evidence of prolactin activity) of a new class of ergolinyl-acylureas is described. Some structure—activity relationshipExpand
Stability and epimerisation behaviour of ergot alkaloids in various solvents
In this paper the stability and degree of epimerisation of six major ergot alkaloids at three different temperature levels (-20 °C, +4 °C and +20 °C) over periods of 18 hours and six weeks isExpand
Enantioselective total synthesis of (+)-lysergic acid, (+)-lysergol, and (+)-isolysergol by palladium-catalyzed domino cyclization of allenes bearing amino and bromoindolyl groups.
Enantioselective total synthesis of the biologically important indole alkaloids (+)-lysergol, (+)-isolysergol, and (+)-lysergic acid is described. Key features of these total synthesis include (1) aExpand
Synthesis and in vitro and in vivo evaluation of dopaminergic ergoline derivatives.
A series of ergoline-amides synthesised in the discovery of new dopaminomimetic agents exhibited in vivo high prolactin lowering activity in rats, and the potential anti-Parkinson activity was evaluated by observation of the contralateral turning behaviour in 6-OH-DA lesioned rats. Expand
Synthesis and structure-activity relationships of new (5R,8R,10R)-ergoline derivatives with antihypertensive or dopaminergic activity.
A series of new (5R,8R,10R)-ergoline derivatives was synthesized, and their antihypertensive and dopaminergic activities were tested in conscious spontaneously hypertensive rats and in rats withExpand
Convenient synthesis of 6-nor-9,10-dihydrolysergic acid methyl ester.
6-Nor-9,10-dihydrolysergic acid methyl ester (V) was evaluated for its effect on blood pressure; at a dose of 30 mg/kg ip, it significantly lowered, diastolic pressure in normotensive rats. Expand
Synthesis of Peptides and Peptidomimetics
It is now over 100 years since the first report of peptide synthesis by Emil Fischer in 1899. Houben-Weyl Synthesis of Peptides and Peptidomimetics, published in the English language, will reflectExpand
Clinical Pharmacokinetics of Cabergoline
The pharmacokinetic properties of cabergoline allow once daily administration in patients with Parkinsons’s disease and twice weekly administration in Patients with hyperprolactinaemia, making this drug advantageous over other dopaminergic agents in term of both therapeutic compliance and better symptom control. Expand